BioCryst Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-20.5231.8811.528.44
Price/Sales ratio
3.032.542.151.88
Earnings per Share (EPS)
$-0.40$0.25$0.71$0.97

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-17.96-17.48-8.45-6.30-8.22-3.32-6.33-13.47-8.63-5.08-6.42-8.22
Price/Sales ratio
59.6615.5917.7016.4640.318.1669.9615.787.883.475.868.16
Price/Book Value ratio
-1.73-1.47-0.82-0.65-1.13-0.47-1.21-2.05-1.46-2.52-5.39-0.47
Price/Cash Flow ratio
-21.06-57.36-8.73-10.07-8.99-4.45-9.08-17.45-13.18-12.10-9.81-4.45
Price/Free Cash Flow ratio
-21.00-41.25-7.94-9.99-8.96-4.43-9.04-17.16-13.07-11.83-9.73-4.43
Price/Earnings Growth ratio
-0.761.32-0.31-1.57-0.32-0.54-0.471.06-0.290.450.21-0.32
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
99.10%96.07%89.75%93.24%97.71%91.60%90.59%95.37%97.56%98.59%97.56%97.56%
Operating Profit Margin
-336.35%-81.73%-184.44%-227.94%-456.20%-203.65%-981.11%-113.07%-54.80%-31.29%-54.80%-456.20%
Pretax Profit Margin
-332.07%-89.14%-209.25%-261.18%-490.25%-222.98%-1026.35%-115.67%-90.23%-68.26%-90.23%-490.25%
Net Profit Margin
-332.07%-89.14%-209.25%-261.18%-490.25%-245.85%-1103.56%-117.11%-91.24%-68.35%-91.24%-490.25%
Effective Tax Rate
-10.66%-11.66%-10.88%-11.95%-2.11%-10.25%-7.52%-1.23%-1.11%-0.13%-1.11%-2.11%
Return on Assets
-33.01%-34.53%-61.37%-36.90%-68.95%-68.49%-58.72%-31.29%-44.93%-43.82%-44.93%-68.95%
Return On Equity
9.65%8.42%9.74%10.41%13.83%14.28%19.20%15.24%16.98%49.73%108.06%13.83%
Return on Capital Employed
-57.80%-65.62%-136.97%-55.51%-121.78%-119.90%-76.29%-36.68%-33.39%-28.26%-33.39%-121.78%
Liquidity Ratios
Current Ratio
1.541.021.231.671.641.773.06N/AN/AN/A4.891.64
Quick Ratio
1.530.991.222.181.621.762.995.304.633.114.501.62
Cash ratio
0.940.440.400.670.381.232.574.862.880.732.880.38
Days of Sales Outstanding
254.5447.21121.4488.6475.87165.52177.1768.3068.1962.7268.19165.52
Days of Inventory outstanding
2.04K310.3267.61-8.10K1.27K138.041.53K793.461.52K2.24K1.52K1.27K
Operating Cycle
2.29K357.54189.05-8.01K1.35K303.561.71K861.761.59K2.30K1.54K1.35K
Days of Payables Outstanding
8.52K1.79K577.311.35K6.02K1.24K4.07K1.39K794.651.63K794.651.24K
Cash Conversion Cycle
-6.22K-1.43K-388.26-9.37K-4.66K-941.40-2.36K-535.52797.58672.75-350.66-4.66K
Debt Ratios
Debt Ratio
0.210.220.560.290.400.450.810.991.331.561.530.40
Debt Equity Ratio
-0.06-0.05-0.09-0.08-0.08-0.09-0.26-0.48-0.50-1.78-2.86-0.09
Long-term Debt to Capitalization
N/AN/A-0.04-0.02-0.03-0.05-0.31-0.94-1.012.281.66-0.03
Total Debt to Capitalization
-0.06-0.05-0.09-0.08-0.08-0.10-0.36-0.94-1.012.281.65-0.08
Interest Coverage Ratio
-9.15-7.58-7.49-6.70-10.26-8.36-12.05N/AN/AN/A-1.49-10.26
Cash Flow to Debt Ratio
-1.28-0.47-1.04-0.79-1.56-1.12-0.49-0.24-0.22-0.11-0.21-1.56
Company Equity Multiplier
-0.29-0.24-0.15-0.28-0.20-0.20-0.32-0.48-0.37-1.13-1.86-0.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.83-0.27-2.02-1.63-4.48-1.83-7.70-0.90-0.59-0.28-0.59-4.48
Free Cash Flow / Operating Cash Flow Ratio
1.001.391.091.001.001.001.001.011.001.021.001.00
Cash Flow Coverage Ratio
-1.28-0.47-1.04-0.79-1.56-1.12-0.49-0.24-0.22-0.11-0.21-1.56
Short Term Coverage Ratio
-1.28-0.47-1.89-1.17-2.74-2.32-4.57N/AN/AN/A-68.31-2.32
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A